Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year total asset growth rate
3Y CAGR
-71.0%/yr
Quarterly compound
Percentile
P64
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.23% |
| Q3 2025 | 4.41% |
| Q2 2025 | 17.61% |
| Q1 2025 | 3.50% |
| Q4 2024 | 0.13% |
| Q3 2024 | 3.56% |
| Q2 2024 | -0.89% |
| Q1 2024 | 4.69% |
| Q4 2023 | 1069.60% |
| Q3 2023 | -91.04% |
| Q2 2023 | 0.95% |
| Q1 2023 | 29.99% |
| Q4 2022 | 173.23% |
| Q3 2022 | -62.79% |
| Q2 2022 | 107.01% |
| Q1 2022 | -27.65% |
| Q4 2021 | -29.13% |
| Q3 2021 | -22.84% |
| Q2 2021 | -14.52% |
| Q1 2021 | 25.55% |
| Q4 2020 | -15.17% |
| Q3 2020 | -9.61% |
| Q2 2020 | 11.87% |
| Q1 2020 | 12.19% |
| Q4 2019 | 7.37% |
| Q3 2019 | -9.00% |
| Q2 2019 | -9.83% |
| Q1 2019 | -10.45% |
| Q4 2018 | -6.37% |
| Q3 2018 | -4.39% |
| Q2 2018 | -4.35% |
| Q1 2018 | 269.21% |
| Q4 2017 | 14.89% |
| Q3 2017 | -13.21% |
| Q2 2017 | 36.37% |
| Q1 2017 | -23.71% |
| Q4 2016 | -26.21% |
| Q3 2016 | -9.79% |
| Q2 2016 | -7.03% |
| Q1 2016 | -11.48% |